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Abstract
Background—Many barriers to cervical cancer screening for Hispanic women have been 
documented, but few effective interventions exist. The Community Preventive Services Task 
Force recommends increasing cervical cancer screening through various methods. Building on this 
evidence, the Centers for Disease Control and Prevention funded the research and testing phases 
for an evidence-based and theoretically grounded intervention designed to increase cervical cancer 
screening among never and rarely screened Hispanic women of Mexican descent. In this article, 
we describe the development process of the AMIGAS (Ayudando a las Mujeres con Información, 
Guía, y Amor para su Salud) intervention, highlight the integration of scientific evidence and 
community-based participatory research principles, and identify opportunities for dissemination, 
adaptation, and implementation of this intervention.
Methods—The AMIGAS team was a collaboration among researchers, promotoras (community 
health workers), and program administrators. The multiyear, multiphase project was conducted in 
Houston, Texas; El Paso, Texas; and Yakima, Washington. The team completed several rounds of 
formative research, designed intervention materials and methodology, conducted a randomized 
controlled trial, created a guide for program administrators, and developed an intervention 
dissemination plan.
Results—Trial results demonstrated that AMIGAS was successful in increasing cervical cancer 
screening among Hispanic women. Adaptation of AMIGAS showed minimal reduction of 
outcomes. Dissemination efforts are underway to make AMIGAS available in a downloadable 
format via the Internet.
Conclusions—Developing a community-based intervention that is evidence-based and 
theoretically grounded is challenging, time-intensive, and requires collaboration among multiple 
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disciplines. Inclusion of key stakeholders—in particular program deliverers and administrators—
and planning for dissemination and translation to practice are integral components of successful 
intervention design. By providing explicit directions for adaptation for program deliverers, 
relevant information for program administrators, and access to the intervention via the Internet, 
AMIGAS is available to help increase cervical cancer screening among Hispanic women and other 
women disproportionately affected by cervical cancer.
Introduction
Cervical cancer incidence and death rates have declined since the introduction of the Pap 
test, yet rates are still higher for Hispanic women than for non-Hispanic white women.1 
Healthy People 2020 has identified targets for cervical cancer incidence (7.1 new cases per 
100,000 women) and mortality (2.2 deaths per 100,000 women)2 that are lower than the 
current incidence and death rates for Hispanic women—10.9 new cases per 100,000 and 2.9 
deaths per 100,000 women, respectively.1 Cervical cancer can be prevented through 
consistent use of the Pap test according to guidelines.3 The most recent guidelines (2012) 
from the United States Preventative Services Task Force, the American Cancer Society, and 
the American College of Obstetricians and Gynecologists recommend a Pap test every three 
years for women 21–30 years; a Pap test and HPV test every 5 years or a Pap test every 3 
years for women 30–65 years.3–6 Healthy People 2020 has also identified a cervical cancer 
screening target (93%).2 Almost 84% of women in the United States report being screened 
for cervical cancer.7 However, Hispanic women, particularly those of Mexican origin and 
those residing in border and rural regions of the United States, are among the least likely to 
be screened.7,8
The Centers for Disease Control and Prevention (CDC) has a long-standing commitment to 
providing cervical cancer screening services to low-income, uninsured women through the 
National Breast and Cervical Cancer Early Detection Program (NBCCEDP) (http://
www.cdc.gov/cancer/nbccedp/). In the past five program years (2006–2011), the NBCCEDP 
has screened over 1.1 million women for cervical cancer.9 However, estimates show that 
between 2004 and 2006 the NBCCEDP was able to provide Pap tests to only 9% of program 
eligible women.10 Importantly, during this same time period, it is estimated that nearly 35% 
of women eligible for the NBCCEDP did not receive cervical cancer screening from any 
source.10 Additionally, while the Patient Protection and Affordable Care Act (ACA)11 will 
provide health insurance coverage for millions of currently uninsured women, a recent study 
estimated that many women eligible for the NBCCEDP will still be without coverage after 
the ACA is implemented.12 For newly insured women—and women still eligible for 
NBCCEDP clinical services—access to coverage for services is not the only barrier that 
must be addressed to increase healthcare use and uptake of recommended and guideline 
consistent screening. A key component of increasing the use of preventive healthcare 
services after the ACA is implemented will be the ability to recruit patients who have 
previously had limited access to the healthcare system. This recruitment will require 
education to increase knowledge of a variety of healthcare services, including cancer 
screening. Effective cervical cancer screening interventions are needed to increase 
awareness and knowledge, address perceptions, and increase uptake of Pap testing—and re-
screening consistent with guidelines—among women who are never and rarely screened. 
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Reducing the cervical cancer screening inequality documented for Hispanic women and 
other medically underserved women will require establishing or expanding community-
based outreach and education programs.
Many barriers to cervical cancer screening for Hispanic women have been documented 
(Table 1).13–18 Still, few evidence- and theory-based interventions have proven effective in 
increasing Pap testing among Hispanic women.19–21 In 2005, the Community Preventive 
Services Task Force (Task Force) found that small media was an effective way to increase 
cervical cancer screening.22 In 2010, the Task Force also found that one-on-one education 
and client reminders were effective strategies for increasing cervical cancer screening.22 
Notably, few intervention strategies in the Community Guide were designed for Hispanic 
women or were intended to be delivered by community health workers. Importantly, the 
literature, outside of the studies included in the systematic reviews, contained few examples 
of interventions that tested the effectiveness of their components’ contribution to the 
primary outcome, thereby providing limited useful information for implementation and 
adaptation of the intervention to community demands or context.23
When desiring an intervention to be used effectively in practice, it is important to build it 
from the beginning with consideration for extant challenges to implementation.24,25 
Partnering with and being responsive to community stakeholders increases the likelihood 
that interventions will be appropriate for and meet the needs of the community when 
disseminated. Decision makers, including program deliverers and program administrators, 
comprise a particularly important stakeholder group when considering adoption or 
implementation of an intervention. Using a community participatory paradigm is one 
method to ensure the perspectives of the ultimate beneficiary, as well as intermediary 
groups, are continually relevant to the intervention development process.26
AMIGAS (Ayudando a las Mujeres con Información, Guía, y Amor para su Salud or 
Helping Women with Information, Guidance, and Love for their Health) is a bilingual 
(English and Spanish) intervention designed to increase receipt of cervical cancer screening 
(Pap testing) among Hispanic women of Mexican descent. (http://www.cdc.gov/cancer/
cervical/what_cdc_is_doing/amigas.htm and http://www.cdc.gov/spanish/cancer/cervical/
what_cdc_is_doing/amigas.htm). The intervention was developed in collaboration with 
community stakeholders, incorporated several behavioral science theories, and used 
Intervention Mapping27 to design the intervention components.28 AMIGAS is delivered by a 
trained promotora (community health worker). The full AMIGAS intervention contains 
several components that may be delivered in combination or separately with equal success in 
increasing screening in the one-on-one format.29
CDC is committed to improving the nation’s health, and this includes the development, 
evaluation, and translation of effective research into practice.30 This article will describe the 
development of the AMIGAS intervention and highlight the integration of scientific 
evidence and community-based participatory research principles. These methods provided a 
foundation that ensured AMIGAS was effective for the intended audience while meeting the 
needs of program deliverers and administrators. We will also identify emerging 
opportunities for dissemination, adaptation, and implementation of the intervention.
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AMIGAS emerged as a product of four broad phases: formative research, materials 
development and testing, intervention trial, and administrator’s guide development and 
testing (Fig. 1). Funded across all phases by CDC, this process was guided by research 
evidence and theory and used a community-based participatory research framework.
The AMIGAS team
The AMIGAS team included researchers, promotoras, and program administrators with 
years of experience in healthcare system management, plain language writing, community 
engagement, behavioral science, methods and statistics, economics, health disparities, and 
cancer prevention and control in the Hispanic community. The Lay Health Advisor Working 
Group (LHAWG), comprised of promotoras and program administrators, was an integral 
participant of the AMIGAS team throughout all phases of the project. These community 
experts were invited to participate in the working group by AMIGAS researchers who knew 
them from reputation and prior research collaborations across the United States.
Formative research
Formative research for the AMIGAS intervention was both qualitative and quantitative and 
was carried out over two time periods. Initial work was completed by researchers at the 
University of Texas-Houston, School of Public Health and funded by CDC. Formative 
research for the AMIGAS intervention was both qualitative and quantitative and was carried 
out over two time periods. A survey informed by multiple behavioral science theories 
(Health Belief Model,31,32 Theory of Reasoned Action,33 Social Cognitive Theory,34 and 
the Transtheoretical Model35,36) was administered to over 500 Hispanic women in the El 
Paso area to gather information about risk perception, barriers and facilitators to cancer 
screening, and group preferences regarding characteristics of interventions. Focus groups 
addressed several key questions including (1) where women receive healthcare, (2) 
healthcare experiences, (3) knowledge and experience with cancer, (4) feelings and beliefs 
about having a Pap test, (5) factors that would make it easier or harder to get a Pap test, and 
(6) sources of social influence. The resultant intervention was in Spanish only and was 
designed for use at the US-Mexico border. It contained a simple instruction guide for 
promotoras, a flipchart, and a video augmented by existing community informational 
brochures. This initial version of AMIGAS was evaluated in individual educational sessions 
with a sample of 200 women.13,14
CDC was interested in developing a cervical cancer screening intervention for Hispanic 
women, including those residing in rural (nonborder) and urban areas. Formative research 
funded by CDC and conducted by Battelle in English and Spanish also provided valuable 
qualitative information about the facilitators and barriers to the receipt of cervical cancer 
screening, and attitudes and opinions about the Pap test for Hispanic women in these new 
locations. In addition, the focus group respondents provided key information about 
intervention design, mode of delivery, messages, and communication strategies.
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The early version of AMIGAS was a promising alternative to investing resources into the 
development of an entirely new intervention. Importantly, CDC identified ways to expand 
the early version of AMIGAS to be relevant to Hispanic women of Mexican descent living 
on the U.S.-Mexico border, in rural areas, and in urban centers.
Focus group and survey results validated that the attitudes, opinions, and perceptions of the 
U.S.-Mexico border participants were consistent with those of the rural and urban 
participants (unpublished data). Collectively, the formative research findings clearly 
indicated that an expanded intervention for Hispanic women would have to do the following 
to succeed: (1) increase knowledge about cervical cancer and Pap testing, (2) encourage 
positive attitudes about Pap testing, (3) acknowledge feelings and concerns about cervical 
cancer screening, (4) target important social referents such as daughters and husbands to 
help encourage Pap testing, (5) reduce system-related barriers by increasing clinic hours and 
availability of bilingual staff or translators, and 6) inform women about low-cost programs 
and services to address concerns about access to healthcare. Major modifications included 
developing an English version of the intervention, revising materials, and developing 
additional intervention components to facilitate uptake by women, promotoras, and program 
administrators.
One last formative component of the expanded AMIGAS included assessing the health 
literacy of a small sample (n = 9) of Hispanic women using the Short Test of Functional 
Health Literacy in Adults (S-TOFHLA) administered in English and Spanish.37,38 Results 
from the S-TOFHLA found a range of functional health literacy among our sample from a 
low of 6 (inadequate) to a high of 36 (adequate) with a mean score of 25 (out of a possible 
36 points).a This information was gathered to inform the language used in message design.
Development of intervention materials
The expanded AMIGAS was designed to be delivered by promotoras, provide women with 
new knowledge and skills, acknowledge and discuss beliefs about cervical cancer and Pap 
testing, reinforce positive behavior, and provide information on local services. New 
materials included a promotora instruction guide; a resource sheet; a promise sheet (mi 
promesa); diagrams of the Pap test procedure and the female reproductive system; and a 
contact sheet (Table 2). Consistent attention to health literacy, particularly the use of plain 
language (http://www.plainlanguage.gov/), in English and Spanish was maintained to ensure 
that the intervention materials were appropriate and culturally relevant for the target 
population.39
Materials were tested in two half-day workshops, in English and Spanish separately, with 17 
promotoras in San Diego, California, and Yakima, Washington. Intervention components 
were assessed for usability, acceptance, and comprehension. Results from these focus 
groups informed revisions to materials and instructions on some of the intervention 
components. After revisions were completed, investigators and the LHAWG conducted a 
final review.
aTOFHLA, Test of Functional Health Literacy in Adults purchased from Peppercorn Books & Press Inc., P.O. Box 693, Snow Camp, 
NC 27349. License number 043/04, issued on June 4, 2004.
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AMIGAS intervention materials were tested for effectiveness—the validated receipt of Pap 
testing at 6 months—together as a full intervention, as well as the relative effectiveness of 
the intervention’s small media components (e.g., flipchart and video). The trial, conducted in 
Houston, Texas (urban); El Paso, Texas (border); and Yakima, Washington (rural), was 
approved by the University of Texas Health Science Center-Houston Committee for the 
Protection of Human Subjects and the Fred Hutchinson Cancer Research Center Institutional 
Review Board. The trial included 613 women who were administered the one-on-one 
version of AMIGAS by a trained promotora. Results indicated that AMIGAS was successful 
in increasing the receipt of Pap tests among Hispanic women in a one-on-one setting 
compared to the control condition (e.g., usual care without intervention materials), and no 
differences existed among the intervention arms.29 The magnitude of the effect in the intent-
to-treat and the per-protocol analyses was greater than had been reported in previous 
interventions to increase screening for cervical cancer in Hispanic women.40,41 The trial also 
included a cost-effectiveness analysis to assess the cost of conducting the intervention at all 
study sites. A report on the findings from the cost-effectiveness evaluation is under review.
Administrator’s guide
A notable departure from traditional implementation materials is found in the AMIGAS 
Administrator’s Guide. Few interventions include a document to assist program 
administrators with decisions about the fit, adoption, adaptation, staffing, and management 
of a selected intervention.40 Discussions with the program administrators in the LHAWG 
had highlighted the need to assist health program administrators in decision making and 
planning related to adoption and implementation of AMIGAS. Components of the AMIGAS 
Administrator’s Guide included an executive summary; intervention purpose, benefits, 
history and development; and sections to aid in the selection, preparation, initiation, 
maintenance, and local adaptation of the intervention. The AMIGAS Administrator’s Guide 
also includes handouts, a sample training agenda for promotoras who will deliver the 
intervention, informational sheets about cervical cancer and Pap testing, and evaluation 
forms. Nine program administrators provided feedback through a questionnaire about 
design, format, scope of information, and program planning guidance. Responses indicated 
that the AMIGAS Administrator’s Guide was well designed and included the necessary 
materials for program administrators to select and implement AMIGAS. Additional advice 
from the review panel prompted a minor revision of some text, graphics and layout for the 
final version. We plan to disseminate the AMIGAS Administrator’s Guide with the 
AMIGAS intervention via the Research-tested Intervention Programs (RTIPs) section of 
Cancer Control P.L.A.N.E.T. (Plan, Link, Act, Network with Evidence-based Tools) (http://
cancercontrolplanet.cancer/gov/) and the CDC website (http://www.cdc.gov/cancer/cervical/
what_cdc_is_doing/amigas.htm).
Conclusions
AMIGAS is a successful intervention developed in partnership with the community and 
designed to increase cervical cancer screening among never and rarely screened Hispanic 
women of Mexican descent. Recruitment of traditionally medically underserved populations 
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requires more effort but can be accomplished when activities are undertaken in conjunction 
with the community.42,43 The extensive formative research, as well as the incorporation of 
community-based participatory research principles, highlight the importance of including 
multiple theoretical and practical components in an intervention designed for 
implementation in the community. Implementation of evidence-based interventions is one 
method to expand preventive healthcare use, including cervical cancer screening. Future 
activities for study investigators, other researchers, and practitioners include revising 
AMIGAS intervention components for use in other traditionally medically underserved 
populations, including other U.S. Hispanic subpopulations, African American women in 
urban and rural areas, and women living in Mexico and Latin America.
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AMIGAS Intervention Development Process.
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Table 1
Barriers to Receiving Pap Test for Hispanic Women
Type of barrier Specific barrier
Informational Negative perceptions of cervical cancer and the Pap test13,14
Low levels of education15
Personal Systems Embarrassment, pain13
Limited access to healthcare16,17
Lack of regular or supportive provider13,17
Low capacity for populations with limited English proficiency18
Healthcare providers Limited or no Spanish language ability18
Male13
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Table 2
AMIGAS Intervention Components
AMIGAS intervention componenta Description
Promotora Instruction Guide Extensive document that provides detailed steps for trained promotoras about how to 
deliver the intervention in individual or group sessions
Video (in Spanish only) Intergenerational Hispanic women discuss the benefits and some of the barriers to 
receiving a Pap test
Flipchart Illustrated document that provides information about cervical cancer and the Pap test
Message cards Interactive tool that provides promotoras with responses to common barriers to Pap 
testing
Body diagrams Illustrations of the female reproductive system and the Pap test procedure
Medical instruments Examples of medical instruments used during the Pap test procedure (e.g., speculum)
Mi promesa (Included in the Promotora Instruction 
Guide)
A “promise sheet” on which women indicate what next step they are willing to take 
toward receipt of a Pap test
Resource Sheet (Included in the Promotora 
Instruction Guide)
A template that can be customized to provide addresses, hours, availability of bilingual 
staff and child care services, and transportation options for local clinics
Games (Included in the Promotora Instruction 
Guide)
Optional games for administration of group version of the intervention that also help to 
reinforce new knowledge about Pap test and cervical cancer
a
All AMIGAS intervention components are in English and Spanish, unless otherwise noted.
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